KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program.
Xu Y, Xu H, Li M, Wu H, Guo Y, Chen J, Shan J, Chen X, Shen J, Ma Q, Liu J, Wang M, Zhao W, Hong J, Qi Y, Yao C, Zhang Q, Yang Z, Qian C, Li J.
Xu Y, et al. Among authors: hong j.
Cancer Lett. 2019 Jul 10;454:78-89. doi: 10.1016/j.canlet.2019.03.049. Epub 2019 Apr 11.
Cancer Lett. 2019.
PMID: 30980868